XML 20 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Grant and collaboration revenue $ 963,203 $ 1,075,270 $ 828,918
Operating expenses:      
Research and development 1,878,652 2,017,350 1,970,859
General and administrative 1,647,268 1,232,368 2,131,426
Total operating expenses 3,525,920 3,249,718 4,102,285
Loss from operations (2,562,717) (2,174,448) (3,273,367)
Other income (expense):      
Interest income 5,213 4,286 1,666
Interest expense (2,590)
Total other income (expense) 2,623 4,286 1,666
Net loss $ (2,560,094) $ (2,170,162) $ (3,271,701)
Basic and diluted:      
Loss per common share (in dollars per share) $ (0.02) $ (0.03) $ (0.08)
Weighted average shares outstanding (in shares) 163,584,755 68,605,817 41,516,514